A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients
Authors
Keywords
Dose prediction methods, Algorithms, Diabetes mellitus, Chinese people, China, Haplotypes, Genotyping, Han Chinese people
Journal
PLoS One
Volume 9, Issue 8, Pages e105250
Publisher
Public Library of Science (PLoS)
Online
2014-08-16
DOI
10.1371/journal.pone.0105250
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
- (2013) Cristina Mazzaccara et al. PLoS One
- Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
- (2012) T. Rusdiana et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Application of Pharmacogenetic-Based Warfarin-Dosing Algorithm in Patients of Han Nationality after Rheumatic Valve Replacement: A Randomized and Controlled Trial
- (2012) MingSong Wang et al. International Journal of Medical Sciences
- Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients
- (2012) Ruijuan Liang et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Genetic polymorphisms are associated with variations in warfarin maintenance dose in Han Chinese patients with venous thromboembolism
- (2012) Wei Zhang et al. PHARMACOGENOMICS
- Predicting warfarin dosage in European–Americans and African–Americans using DNA samples linked to an electronic health record
- (2012) Andrea H Ramirez et al. PHARMACOGENOMICS
- Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation
- (2012) Jie Yang et al. THROMBOSIS AND HAEMOSTASIS
- A new algorithm to predict warfarin dose from polymorphisms of CYP4F2, CYP2C9 and VKORC1 and clinical variables: Derivation in Han Chinese patients with non valvular atrial fibrillation
- (2012) Meng Wei et al. THROMBOSIS AND HAEMOSTASIS
- Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians
- (2011) Ivet M Suriapranata et al. BMC Medical Genetics
- Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients
- (2011) Jung Ran Choi et al. JOURNAL OF HUMAN GENETICS
- Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients
- (2011) Shi-Long Zhong et al. Pharmacogenetics and Genomics
- Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation
- (2011) Inna Y. Gong et al. PLoS One
- Effects of CYP4F2 and GGCX genetic variants on maintenance warfarin dose in a multiethnic Asian population
- (2011) Sze Ling Chan et al. THROMBOSIS AND HAEMOSTASIS
- Influence of GGCX genotype on warfarin dose requirements in Chinese patients
- (2011) Sheng-Wen Huang et al. THROMBOSIS RESEARCH
- A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans
- (2010) D Voora et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing
- (2010) P Lenzini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China
- (2010) Qiang Gu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese
- (2010) P.-C. Cha et al. HUMAN MOLECULAR GENETICS
- Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients
- (2010) Joyce H. S. You et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Genes Involved in the Metabolism of Poly-Unsaturated Fatty-Acids (PUFA) and Risk for Crohn's Disease in Children & Young Adults
- (2010) Irina Costea et al. PLoS One
- Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1 , F7 , GGCX , CALU , EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapy
- (2010) B. Luxembourg et al. THROMBOSIS AND HAEMOSTASIS
- Genotypes Associated With Reduced Activity of VKORC1 and CYP2C9 and Their Modification of Acenocoumarol Anticoagulation During the Initial Treatment Period
- (2009) M Teichert et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients
- (2009) E Pautas et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A genome-wide association study of acenocoumarol maintenance dosage
- (2009) Martina Teichert et al. HUMAN MOLECULAR GENETICS
- CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
- (2009) M. G. McDonald et al. MOLECULAR PHARMACOLOGY
- Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients
- (2009) Sheng-Wen Huang et al. Pharmacogenetics and Genomics
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
- (2008) G. M. Cooper et al. BLOOD
- Genetic factors contribute to patient-specific warfarin dose for Han Chinese
- (2008) Ting-Liang Wang et al. CLINICA CHIMICA ACTA
- Association of a Functional Cytochrome P450 4F2 Haplotype with Urinary 20-HETE and Hypertension
- (2008) H. Liu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search